NewAmsterdam Pharma Warrant
NAMSW
9 hedge funds and large institutions have $28.1M invested in NewAmsterdam Pharma Warrant in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
8% more capital invested
Capital invested by funds: $26M → $28.1M (+$2.09M)
0.28% more ownership
Funds ownership: 28.18% → 28.46% (+0.28%)
0% more funds holding
Funds holding: 9 → 9 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$280K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.03K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FLSM
1
Frazier Life Sciences Management
Palo Alto,
California
| $10.7M | – | – | – |
|
|
RCM
2
RA Capital Management
Boston,
Massachusetts
| $7.12M | – | – | – |
|
|
AAA
3
Affinity Asset Advisors
New York
| $5.34M | – | – | – |
|
|
BCLSI
4
Bain Capital Life Sciences Investors
Boston,
Massachusetts
| $2.14M | – | – | – |
|
|
DM
5
Deerfield Management
New York
| $1.98M | – | – | – |
|
|
AC
6
Aristeia Capital
Greenwich,
Connecticut
| $343K | – | – | – |
|
|
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $319K | +$280K | +12,798 | +602% |
|
|
VI
8
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $143K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $8.52K | +$1.03K | +47 | +12% |
|
NAMSW Hedge Fund Activity: Q2 2026 in Review
9 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q2 2026, worth a combined $28.1M — up 8% from $26M a quarter earlier.
Fund positioning in NAMSW was balanced in Q2 2026: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $280K.
- 9 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $28.1M of NewAmsterdam Pharma Warrant stock for Q2 2026, up 8% quarter-over-quarter.
- 0 funds opened new NewAmsterdam Pharma Warrant positions in Q2 2026 and 0 closed out.
- The largest NewAmsterdam Pharma Warrant buyer in Q2 2026 was Wolverine Asset Management, an estimated $280K added.
Based on aggregated 13F filings for Q2 2026.